Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Rothman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Zachary - $25.20M in MRK purchases and sales in the last 12 months
- Richard R. Deluca - $11.29M in MRK purchases and sales in the last 12 months
- Adam H. Schechter - $8.44M in LH purchases and sales in the last 12 months
- Chirfi Guindo - $8.15M in MRK purchases and sales in the last 12 months
- David Michael Williams - $8.13M in MRK purchases and sales in the last 12 months
- Robert M. Davis - $5.60M in MRK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Rothman?
Paul Rothman is a corporate insider, tracked as Director of Merck & Co., Inc. (MRK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Paul Rothman last file a Form 4?
The most recent primary Form 4 on record is dated 2 June 2026, one of 3 filings going back to 2026.
